Literature DB >> 17492346

[Treatment options in painful diabetic polyneuropathy].

Juan J Archelos1.   

Abstract

Distal symmetrical polyneuropathy is the most frequent manifestation of diabetic neuropathy and crucially contributes to the development of diabetic foot and subsequent amputation in 70 to 80% of all cases. In 10 to 15% of affected patients considerable pain is present, in particular in early diabetic polyneuropathy. This review summarizes evidence based data on prevention, neuroregenerative, and symptomatic treatment of painful diabetic polyneuropathy. The most important clinical trials on treatment and prevention are presented. Conclusions from these clinical studies in particular detailed treatment recommendations including dosage and side effects are given. Combined treatments and escalating therapies for severe pain syndromes are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492346     DOI: 10.1007/s00508-007-0795-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  90 in total

1.  Clinical evaluation and investigation of neuropathy.

Authors:  Hugh J Willison; John B Winer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 2.  Duloxetine in diabetic neuropathy.

Authors:  Timothy R Smith
Journal:  Expert Opin Pharmacother       Date:  2006-02       Impact factor: 3.889

3.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

4.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

5.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

6.  Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.

Authors:  C Peter N Watson; Dwight Moulin; Judith Watt-Watson; Allan Gordon; John Eisenhoffer
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Inflammatory vasculopathy in multifocal diabetic neuropathy.

Authors:  Gérard Said; Catherine Lacroix; Pierre Lozeron; Angèle Ropert; Violaine Planté; David Adams
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

Authors:  M Rowbotham; N Harden; B Stacey; P Bernstein; L Magnus-Miller
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

Review 9.  Painful peripheral neuropathy and its nonsurgical treatment.

Authors:  Gil I Wolfe; Jaya R Trivedi
Journal:  Muscle Nerve       Date:  2004-07       Impact factor: 3.217

10.  Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.

Authors:  J A Rull; R Quibrera; H González-Millán; O Lozano Castañeda
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.